Clinical trial
DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of…
NCT00099281 · YM BioSciences, Industry · Terminated
Key facts
| NCT number | NCT00099281 |
|---|---|
| Title | DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer |
| Official title | A Phase III Study of DPPE Combined With Epirubicin and Cyclophosphamide vs Epirubicin and Cyclophosphamide Alone as First Line Treatment in Metastatic/Recurrent Breast Cancer |
| Lead sponsor | YM BioSciences, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Metastases |
| Intervention type | Drug |
| Interventions | YMB 1002 |
| Enrollment | 700 |
| Start date | May 1, 2004 |
| Completion | Jun 1, 2006 |
| First posted | Dec 10, 2004 |
| Last update posted | Feb 28, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: